Clinical Trials on Advanced Nonhematological Neoplasms in United Kingdom
Total 49796 results
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Nonhematological MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, France, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.WithdrawnAdvanced Nonhematologic MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Basal Cell | Advanced Nonhematologic MalignanciesUnited States
-
Metronome TherapeuticsUnknownNonhematologic MalignanciesUnited States
-
Aegera TherapeuticsTerminated
-
University College, LondonRecruiting
-
Eli Lilly and CompanyCompletedAdvanced CancerUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedCancer, Advanced Solid TumorsUnited Kingdom
-
Stemline Therapeutics, Inc.CompletedStudy of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors With Advanced Solid TumorsAdvanced Solid TumorUnited Kingdom
-
Cancer Research UKTerminatedAdvanced Solid TumoursUnited Kingdom
-
PfizerCompletedAdvanced Non-Hematologic MalignanciesUnited Kingdom
-
University of California, Los AngelesUniversity of California, San Francisco; University of California, IrvineActive, not recruitingAdvanced Cancer | Advance Care Planning | Advance DirectivesUnited States
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited Kingdom, United States
-
PharmaMarCompletedAdvanced Solid TumorsUnited Kingdom, Switzerland
-
Heidelberg Pharma AGTerminatedAdvanced Solid TumoursUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid Metastatic TumorUnited Kingdom
-
Nerviano Medical SciencesTerminatedAdvanced/Metastatic Solid TumorsUnited Kingdom, France
-
PharmaMarCompletedSpecific Advanced Solid TumorsSpain, United Kingdom
-
Eisai Inc.Completed
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States
-
Heidelberg Pharma AGTerminatedAdvanced Solid TumoursUnited Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedLymphoma | Nonhematologic MalignanciesUnited States
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomUnknownAdvanced Solid MalignanciesUnited Kingdom
-
King's College LondonCalouste Gulbenkian Foundation; Centro Hospitalar Lisboa CentralCompletedAdvanced CancerUnited Kingdom
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedAdvanced Malignant Neoplasm | Locally Advanced Malignant NeoplasmUnited States
-
OSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Exscientia AI LimitedGT Apeiron LLCRecruitingAdvanced Solid TumorUnited Kingdom, Belgium
-
BioNTech SEGenmabRecruitingAdvanced Malignant Solid TumorUnited States, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
AstraZenecaCompletedSafety and Tolerability, | Advanced Solid Malignancy, | Pharmacokinetics, Pharmacodynamics, | Tumour Response,United Kingdom, Netherlands
-
Advanced Integrative Medical Science InstituteRecruitingNeoplasms | Advanced Solid Tumor | Advanced Cancer | Oncology | Neoplasm MalignantUnited States
-
UCB Biopharma SRLCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Royal Marsden NHS Foundation TrustUnknownAdvanced Gastrointestinal CancersUnited Kingdom
-
BioInvent International ABMerck Sharp & Dohme LLCRecruitingAdvanced MalignanciesUnited Kingdom, Denmark, Hungary, Russian Federation
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
Royal Marsden NHS Foundation TrustPfizer; Roche Pharma AG; Institute of Cancer Research, United KingdomUnknownBreast Cancer | Advanced Solid TumoursUnited Kingdom
-
University of California, San FranciscoCompletedIntegrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced CancerAdvanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Nuvectis Pharma, Inc.RecruitingAdvanced Solid TumorUnited States, United Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAdvanced Malignant NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Malignant NeoplasmUnited States
-
AstraZenecaParexelTerminatedAdvanced Solid TumorsUnited Kingdom
-
BicycleTx LimitedRecruitingAdvanced Solid TumorUnited States, United Kingdom
-
University of WolverhamptonThe Royal Wolverhampton Hospitals NHS TrustRecruitingAdvanced Prostate CarcinomaUnited Kingdom